Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Front Endocrinol (Lausanne). 2023 Mar 23;14:1157123. doi: 10.3389/fendo.2023.1157123. eCollection 2023.
Previous studies had showed divergent findings on the associations of C-peptide and/or uric acid (UA) with renal dysfunction odds in patients with type 2 diabetes mellitus (T2DM). We hypothesized that there were non-linear relationships between C-peptide, UA and renal dysfunction odds. This study aimed to further investigate the relationships of different stratification of C-peptide and UA with renal dysfunction in patients with T2DM.
We conducted a cross-sectional real-world observational study of 411 patients with T2DM. The levels of fasting C-peptide, 2h postprandial C-peptide, the ratio of fasting C-peptide to 2h postprandial C-peptide (C0/C2 ratio), UA and other characteristics were recorded. Restricted cubic spline (RCS) curves was performed to evaluated the associations of stratified C-peptide and UA with renal dysfunction odds.
Fasting C-peptide, C0/C2 ratio and UA were independently and significantly associated with renal dysfunction in patients with T2DM as assessed by multivariate analyses (p < 0.05). In especial, non-linear relationships with threshold effects were observed among fasting C-peptide, UA and renal dysfunction according to RCS analyses. Compared with patients with 0.28 ≤ fasting C-peptide ≤ 0.56 nmol/L, patients with fasting C-peptide < 0.28 nmol/L (OR = 1.38, p = 0.246) or fasting C-peptide > 0.56 nmol/L (OR = 1.85, p = 0.021) had relatively higher renal dysfunction odds after adjusting for confounding factors. Similarly, compared with patients with 276 ≤ UA ≤ 409 μmol/L, patients with UA < 276 μmol/L (OR = 1.32, p = 0.262) or UA > 409 μmol/L (OR = 6.24, p < 0.001) had relatively higher odds of renal dysfunction.
The renal dysfunction odds in patients with T2DM was non-linearly associated with the levels of serum fasting C-peptide and UA. Fasting C-peptide and UA might have the potential role in odds stratification of renal dysfunction.
之前的研究表明,2 型糖尿病(T2DM)患者的 C 肽和/或尿酸(UA)与肾功能障碍的关联存在分歧。我们假设 C 肽、UA 与肾功能障碍的概率之间存在非线性关系。本研究旨在进一步探讨不同分层的 C 肽和 UA 与 T2DM 患者肾功能障碍的关系。
我们对 411 例 T2DM 患者进行了横断面真实世界观察性研究。记录了空腹 C 肽、餐后 2 小时 C 肽、空腹 C 肽与餐后 2 小时 C 肽的比值(C0/C2 比值)、UA 及其他特征。采用限制性立方样条(RCS)曲线评估分层 C 肽和 UA 与肾功能障碍概率的关系。
多变量分析显示,空腹 C 肽、C0/C2 比值和 UA 与 T2DM 患者的肾功能障碍独立且显著相关(p<0.05)。特别是,根据 RCS 分析,空腹 C 肽、UA 与肾功能障碍之间存在非线性关系,且存在阈值效应。与空腹 C 肽 0.28≤0.56 nmol/L 的患者相比,空腹 C 肽<0.28 nmol/L(OR=1.38,p=0.246)或空腹 C 肽>0.56 nmol/L(OR=1.85,p=0.021)的患者在调整混杂因素后肾功能障碍的概率较高。同样,与 UA 276≤409 μmol/L 的患者相比,UA<276 μmol/L(OR=1.32,p=0.262)或 UA>409 μmol/L(OR=6.24,p<0.001)的患者肾功能障碍的概率较高。
T2DM 患者的肾功能障碍概率与血清空腹 C 肽和 UA 水平呈非线性相关。空腹 C 肽和 UA 可能在肾功能障碍的概率分层中具有潜在作用。